Advertisement

Uterine Carcinosarcoma in A Postmenopausal Woman: A Rare Case Report

  • Anjili Kumari
  • Sangeeta Pankaj
  • Jaya Kumari
  • Anita Kumari
  • Syed Nazneen
  • Vijayanand Choudhary
Case Report
  • 13 Downloads

Abstract

Uterine carcinosarcomas are rare tumors accounting for about 2–4% of all uterine cancer and with a poor prognosis with 5-year survival of only 21–39%. These are highly aggressive tumors and usually diagnosed with distant metastasis at the initial diagnosis. The origin of this tumor has been studied extensively, and these are now believed to be metaplastic carcinomas. The treatment of the early-stage disease is surgery, and in the late stages the role of adjuvant chemotherapy and radiotherapy is debated. We report here a case of the early-stage uterine carcinosarcoma in a postmenopausal woman.

Keywords

Uterine carcinosarcomas Postmenopausal Aggressive tumors Mesodermal mixed tumor 

Notes

Compliance with Ethical Standards

Conflict of interest

We declare that this manuscript is original, and it has not been published anywhere before and is not currently being considered for publication elsewhere. We also confirm that the authors do not have any conflict of interest associated with publication of this work, and no significant financial support for this work has been received to influence the outcome. The manuscript is read and approved, and consent is given by all the authors. We give our permission to reproduce any material of the article.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

References

  1. 1.
    Kanthan R, Senger JL. Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int. 2011;2011:470795.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lacour RA, Euscher E, Atkinson EN, Sun CC, Ramirez PT, Coleman RL, Brown J, Gano JB, Burke TW, Ramondetta LM. A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. Int J Gynecol Cancer. 2011;21(3):517–22.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Galaal K, van der Heijden E, Godfrey K, Naik R, Kucukmetin A, Bryant A, et al. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev. 2013;28(2):CD006812.Google Scholar
  4. 4.
    Cantrell LA, Havrilesky L, Moore DT, O’Malley D, Liotta M, et al. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma. Gynecol Oncol. 2012;127(1):22–6.CrossRefPubMedGoogle Scholar

Copyright information

© Association of Gynecologic Oncologists of India 2018

Authors and Affiliations

  • Anjili Kumari
    • 1
  • Sangeeta Pankaj
    • 1
  • Jaya Kumari
    • 1
  • Anita Kumari
    • 1
  • Syed Nazneen
    • 1
  • Vijayanand Choudhary
    • 2
  1. 1.Gynecological Oncology, RCCIGIMS, PatnaPatnaIndia
  2. 2.PathologyIGIMS, PatnaPatnaIndia

Personalised recommendations